Company Search:
Advanced Search
Sponsored Links
Spero Therapeutics Inc Company Snapshot
Spero Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Spero Therapeutics Inc with three other companies in this sector in the United States: Revance Therapeutics Inc (2018 sales of $3.73 million of which 100% was Botulinum Toxin Products), Aytu Bioscience Inc ($3.66 million of which 93% was Aytu), and Starpharma Holdings Limited ($3.83 million of which 100% was Dendritic).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Spero Therapeutics Inc
  Stock Performance Chart for Spero Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 10.53
(Figures in U.S. Dollars)
1 Week -0.7%   13 Weeks -4.5%  
4 Weeks 14.1%   52 Weeks 22.9%  
Spero Therapeutics Inc Key Data:
  Ticker: SPRO Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 3,966,000
(Year Ending Jan 2019).
Employees: 41
  Currency: U.S. Dollars Market Cap: 196,521,706
  Fiscal Yr Ends: December Shares Outstanding: 18,663,030
  Share Type: Common Closely Held Shares: 4,081,373
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.